Telemedicine in Patients Affected by Chronic Liver Disease : A Scoping Review of Clinical Outcomes and the Devices Evaluated
For patients with chronic liver disease (CLD), telemedicine is emerging as a useful tool to prevent liver decompensation or hospitalization, allowing access to and the decentralization of care, even for patients with limited resources. However, research and attendant evidence are still lacking; thus, this review aims to systematically explore the topic of telemonitoring for CLD to describe the currently used tools and clinical outcomes. The review was conducted by using key terms on PubMed/EMBASE and searching for observational studies or clinical trials (according to PRISMA recommendations) that were published between 6 April 2013 and 6 April 2023 to keep the technological framework limited to the last 10 years. The studies were described and grouped according to the aim of telemonitoring, the underlying disease, and the tools adopted to achieve remote monitoring. A total of 32 articles met the inclusion criteria. Of these, 11 articles report the successful use of a telehealth program to support and improve access to care in the management of HCV-related cirrhosis, eight articles examine the efficacy of telemedicine for remote monitoring interventions to prevent or decrease the risk of decompensation in high-risk patients, and five articles examine improvements in the physical performance and quality of life of cirrhotic patients through telehealth rehabilitation programs. Four studies were completed during the recent COVID-19 pandemic. Telehealth has the potential to provide and expand treatment access and reduce barriers to care for the most disadvantaged patients and might be able to reduce the need for hospital readmission for CLD, though most practice to test feasibility is still in the pilot stage.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Journal of clinical medicine - 12(2023), 15 vom: 04. Aug. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Capuano, Paolo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ascites |
|---|
| Anmerkungen: |
Date Revised 14.08.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/jcm12155128 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360680372 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360680372 | ||
| 003 | DE-627 | ||
| 005 | 20231226083528.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm12155128 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360680372 | ||
| 035 | |a (NLM)37568531 | ||
| 035 | |a (PII)5128 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Capuano, Paolo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Telemedicine in Patients Affected by Chronic Liver Disease |b A Scoping Review of Clinical Outcomes and the Devices Evaluated |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 14.08.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a For patients with chronic liver disease (CLD), telemedicine is emerging as a useful tool to prevent liver decompensation or hospitalization, allowing access to and the decentralization of care, even for patients with limited resources. However, research and attendant evidence are still lacking; thus, this review aims to systematically explore the topic of telemonitoring for CLD to describe the currently used tools and clinical outcomes. The review was conducted by using key terms on PubMed/EMBASE and searching for observational studies or clinical trials (according to PRISMA recommendations) that were published between 6 April 2013 and 6 April 2023 to keep the technological framework limited to the last 10 years. The studies were described and grouped according to the aim of telemonitoring, the underlying disease, and the tools adopted to achieve remote monitoring. A total of 32 articles met the inclusion criteria. Of these, 11 articles report the successful use of a telehealth program to support and improve access to care in the management of HCV-related cirrhosis, eight articles examine the efficacy of telemedicine for remote monitoring interventions to prevent or decrease the risk of decompensation in high-risk patients, and five articles examine improvements in the physical performance and quality of life of cirrhotic patients through telehealth rehabilitation programs. Four studies were completed during the recent COVID-19 pandemic. Telehealth has the potential to provide and expand treatment access and reduce barriers to care for the most disadvantaged patients and might be able to reduce the need for hospital readmission for CLD, though most practice to test feasibility is still in the pilot stage | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a ascites | |
| 650 | 4 | |a cirrhosis | |
| 650 | 4 | |a digital medicine | |
| 650 | 4 | |a encephalopathy | |
| 650 | 4 | |a home-medicine | |
| 650 | 4 | |a outcomes | |
| 650 | 4 | |a remote medicine | |
| 650 | 4 | |a teleconsult | |
| 650 | 4 | |a telemonitoring | |
| 700 | 1 | |a Hileman, Bethany |e verfasserin |4 aut | |
| 700 | 1 | |a Tigano, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Magro, Bianca |e verfasserin |4 aut | |
| 700 | 1 | |a Lo Re, Vincenzina |e verfasserin |4 aut | |
| 700 | 1 | |a Liotta, Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Sciveres, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Ranucci, Giusy |e verfasserin |4 aut | |
| 700 | 1 | |a Provenzani, Alessio |e verfasserin |4 aut | |
| 700 | 1 | |a Burgio, Gaetano |e verfasserin |4 aut | |
| 700 | 1 | |a Scardulla, Cesare |e verfasserin |4 aut | |
| 700 | 1 | |a Arcadipane, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a Martucci, Gennaro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 12(2023), 15 vom: 04. Aug. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:15 |g day:04 |g month:08 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm12155128 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 15 |b 04 |c 08 | ||